Expression of p16INK4a/p16α and p19ARF/p16β is frequently altered in non-small cell lung cancer and correlates with p53 overexpression

Oncogene

Volumn 17, Issue 21, 1998, Pages 2779-2785

  Vonlanthen, Silvia ^a   Heighway, Jim ^b   Tschan, Mario P ^a   Borner, Markus M ^a   Altermatt, Hans J ^a   Kappeler, Andreas ^a   Tobler, Andreas ^a   Fey, Martin F ^a   Thatcher, Nick ^b   Yarbrough, Wendell G ^c   Betticher, Daniel C ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b CHRISTIE HOSPITAL   (United Kingdom)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

CDKN2; Methylation; Non small cell lung carcinoma; p16INK4a p16 ; p19ARF p16 ; p53

Indexed keywords

MESSENGER RNA; PROTEIN P16; PROTEIN P53; RETINOBLASTOMA PROTEIN; CYCLIN D1; DNA; PROTEIN; PROTEIN P14ARF; PROTEIN P16INK4A; RNA; TUMOR PROTEIN;

ANIMAL CELL; ARTICLE; CARTILAGE CELL; CELL CYCLE; CONTROLLED STUDY; DOWN REGULATION; EPITHELIUM CELL; EXON; FIBROBLAST; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; LUNG NON SMALL CELL CANCER; LYMPHOCYTE; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR SUPPRESSOR GENE; AGED; ANIMAL; BIOSYNTHESIS; CELL CULTURE; CELL CYCLE G1 PHASE; CELL STRAIN COS1; CELL STRAIN K 562; DNA METHYLATION; FEMALE; GENE; GENE EXPRESSION REGULATION; GENETICS; HELA CELL; LUNG TUMOR; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY;

ANIMALIA;

AGED; ANIMALS; CARCINOMA, NON-SMALL-CELL LUNG; COS CELLS; CYCLIN D1; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DNA METHYLATION; DNA, NEOPLASM; EXONS; FEMALE; G1 PHASE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, OVERLAPPING; GENES, P16; GENES, P53; GENES, TUMOR SUPPRESSOR; HELA CELLS; HUMANS; K562 CELLS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM PROTEINS; PROTEINS; RETINOBLASTOMA PROTEIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, NEOPLASM; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P14ARF; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0032569736     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1202501     Document Type: Article

References (46)

1. Arap W, Knudsen E, Sewell DA, Sidransky D, Wang JY, Huang JH and Cavenee WK. (1997). Oncogene, 15, 2013-2020.
2. Betticher DC, Heighway J, Hasleton PS, Altermatt HJ, Ryder WD, Cerny T and Thatcher N. (1996). Br. J. Cancer, 73, 294-300.
3. Betticher DC, White GR, Vonlanthen S, Liu X, Kappeler A, Altermatt HJ, Thatcher N and Heighway J. (1997). Int. J. Cancer, 74, 556-562.
4. Blin N and Stafford DW. (1976). Nucl. Acids Res., 9, 2303-2308.
5. Borner MM, Brousset P, Pfanner-Meyer B, Bacchi M, Vonlanthen S, Hotz MA, Altermatt HJ, Schlaifer D, Reed JC and Betticher DC. (1998). Br. J. Cancer, in press.
6. Ferguson-Smith AC, Sasaki H, Cattanach BM and Surani MA. (1993). Nature, 362, 751-755.
7. Geradts J, Kratzke RA, Niehans GA and Lincoln CE. (1995). Cancer Res., 55, 6006-6011.
8. Gonzalez-Zulueta M, Bender CM, Yang AS, Nguyen T, Beart RW, Van Turnout JM and Jones PA. (1995a). Cancer Res., 55, 4531-4535.
9. Gonzalez-Zulueta M, Shibata A, Ohneseit PF, Spruck CHr, Busch C, Shamaa M, El-Baz M, Nichols PW, Gonzalgo ML, Elbaz M, Nichols PW, Gonzalgo ML, Malström P and Jones PA. (1995b). J. Natl. Cancer Inst., 87, 1383-1393.
10. Gruis NA, Weaver-Feldhaus J, Liu Q, Frye C, Eeles R, Orlow I, Lacombe L, Ponce-Castaneda V, Lianes P, Latres E, Skolnick M, Cordon-Cardo C and Kamb A. (1995). Am. J. Pathol., 146, 1199-1206.
11. Haber DA. (1997). Cell, 91, 555-558.
12. Hara E, Smith R, Parry D, Tahara H, Stone S and Peters G. (1996). Mol. Cell. Biol., 16, 859-867.
13. Herman JG, Civin CI, Issa JP, Collector MI, Sharkis SJ and Baylin SB. (1997). Cancer Res., 57, 837-841.
14. Herman JG, Merlo A, Mao L, Lapidus RG, Issa JP, Davidson NE, Sidransky D and Baylin SB. (1995). Cancer Res., 55, 4525-4530.
15. Heyman M, Rasool O, Brandter LB, Liu Y, Grander D, Einhorn S and Soderhall S. (1996). Blood, 87, 1657-1658.
16. Hussussian CJ, Struewing JP, Goldstein AM, Higgins PA, Ally DS, Sheahan MD, Clark Jr WH, Tucker MA and Dracopoli NC. (1994). Nat. Genet., 8, 15-21.
17. Issa JP, Ottaviano YL, Celano P, Hamilton SR, Davidson NE and Baylin SB. (1994). Nat. Genet., 7, 536-540.
18. Kamb A, Gruis NA, Weaver-Feldhaus J, Liu Q, Harshman K, Tavtigian SV, Stockert E, Day Sr R, Johnson BE and Skolnick MH. (1994). Science, 264, 436-440.
19. Kamijo T, Zindy F, Roussel MF, Quelle DE, Downing JR, Ashmun RA, Grosveld G and Sherr CJ. (1997). Cell, 91, 649-659.
20. Kelley MJ, Nakagawa K, Steinberg SM, Mulshine JL, Kamb A and Johnson BE. (1995). J. Natl. Cancer Inst., 87, 756-761.
21. Laird PW and Jaenisch R. (1994). Hum. Mol. Genet., 3 Spec No, 1487-1495.
22. Liggett Jr, WH, Sewell DA, Rocco J, Ahrendt SA, Koch W and Sidransky D. (1996). Cancer Res., 56, 4119-4123.
23. Mao L, Merlo A, Bedi G, Shapiro GI, Edwards CD, Rollins BJ and Sidransky D. (1995). Cancer Res., 55, 2995-2997.
24. Marchetti A, Buttitta F, Pellegrini S, Bertacca G, Chella A, Carnicelli V, Tognoni V, Filardo A, Angeletti CA and Bevilacqua G. (1997). J. Pathol., 181, 178-182.
25. Merlo A, Herman JG, Mao L, Lee DJ, Gabrielson E, Burger PC, Baylin SB and Sidransky D. (1995). Nat. Med., 1, 686-692.
26. Nobori T, Miura K, Wu DJ, Lois A, Takabayashi K and Carson DA. (1994). Nature, 368, 753-756.
27. Okamoto A, Demetrick DJ, Spillare EA, Hagiwara K, Hussain SP, Bennett WP, Forrester K, Gerwin B, Serrano M, Beach DH and Harris CC. (1994). Proc. Natl. Acad. Sci. USA, 91, 11045-11049.
28. Otterson GA, Kratzke RA, Coxon A, Kim YW and Kaye FJ. (1994). Oncogene, 9, 3375-3378.
29. Otterson GA, Khleif SN, Chen W, Coxon AB and Kaye FJ. (1995). Oncogene, 11, 1211-1216.
30. Pomerantz J, Schreiber-Agus N, Liegeois NJ, Silverman A, Allans L, Chin L, Potes J, Chen K, Orlow I, Lee HW, Cordon-Cardo C and DePinho RA. (1998). Cell, 92, 713-723.
31. Quelle DE, Zindy F, Ashmun RA and Sherr CJ. (1995). Cell, 83, 993-1000.
32. Quelle DE, Cheng M, Ashmun RA and Sherr CJ. (1997). Proc. Natl. Acad. Sci. USA, 94, 669-673.
33. Sandig V, Brand K, Herwig S, Lukas J, Bartek J and Strauss M. (1997). Nat. Med., 3, 313-319.
34. Serrano M, Lee H, Chin L, Cordon-Cardo C, Beach D and DePinho RA. (1996). Cell, 85, 27-37.
35. Serrano M, Lin AW, McCurrach ME, Beach D and Lowe SW. (1997). Cell, 88, 593-602.
36. Shapiro GI, Edwards CD, Kobzik L, Godleski J, Richards W, Sugarbaker DJ and Rollins BJ. (1995). Cancer Res., 55, 505-509.
37. Shapiro GI, Edwards CD, Ewen ME and Rollins BJ. (1998). Mol. Cell. Biol., 18, 378-387.
38. Shores C, Liu E and Yarbrough W. (1997). Proc. Am. Ass. Cancer Res., 38, 277.
39. Singer-Sam J and Riggs AD. (1993). Exs., 64, 358-384.
40. Stone S, Duyananth P, Jiang P, Weaver-Feldhaus JM, Tavtigian SV, Cannon-Albright L and Kamb A. (1995a). Oncogene, 11, 987-991.
41. Stone S, Jiang P, Dayananth P, Tavtigian SV, Katcher H, Parry D, Peters G and Kamb A. (1995b). Cancer Res., 55, 2988-2994.
42. Swafford DS, Middleton SK, Palmisano WA, Nikula KJ, Tesfaigzi J, Baylin SB, Herman JG and Belinsky SA. (1997). Mol. Cell. Biol., 17, 1366-1374.
43. Tam SW, Shay JW and Pagano M. (1994). Cancer Res., 54, 5816-5820.
44. UICC-American Joint Committee on Cancer. (1987). Manual for Staging of Cancer. 3rd edition. JB Lippincott: Philadelphia.
45. WHO (1981). Histological Typing of Lung Tumours. 2nd edn. Geneva, World Health Organisation.
46. Zhang Y, Xiong Y and Yarbrough WG. (1998). Cell, 92, 725-734.